NEW YORK (GenomeWeb) – Startup molecular diagnostic firm Prominex announced today it has raised $4 million in Series A1 financing. 

The funding comes from Casdin Capital and Paul Thomas, a cofounder and CEO of Prominex and former CEO of Roka Bioscience. 

Prominex will use the funding to further develop its technology — including a coupled hairpin amplification system, or CHASE, and waveguide detection — for highly multiplexed infectious disease assays, in partnership with point-of-care instrument developer Invetech.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.